Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pain
|
April 1, 1995
Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron
Harald Schwörer, Heinz Hartmann, Giuliano Ramadori
Scandinavian Journal of Gastroenterology
|
February 18, 2006
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication
Oliver Schildgen, Heinz Hartmann, Wolfram H Gerlich
Zeitschrift Fur Gastroenterologie
|
November 9, 2020
[Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany]
Dietrich Hüppe, Claus Niederau, Yvonne Serfert, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis
Corinna Hopf, Renate Grieshaber, Heinz Hartmann, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
March 13, 2016
[Inflammatory Bowel Disease Competence Network]
Stefan Schreiber, Heinz Hartmann, Wolfgang Kruis, et al.
BMC Gastroenterology
|
July 10, 2020
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
Ulf Helwig, Michael Mross, Stefan Schubert, et al.
The New England Journal of Medicine
|
April 28, 2006
Variant of hepatitis B virus with primary resistance to adefovir
Oliver Schildgen, Hueseyin Sirma, Anneke Funk, et al.
European Journal of Gastroenterology & Hepatology
|
July 14, 2020
Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study
Maria M Gabriel, Gerald Kircheis, Svenja Hardtke, et al.
Digestive Diseases and Sciences
|
November 19, 2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
Jörg Petersen, Renate Heyne, Stefan Mauss, et al.
The Lancet. Gastroenterology & Hepatology
|
August 19, 2017
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones, Pol F Boudes, Mark G Swain, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pain
|
April 1, 1995
Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron
Harald Schwörer, Heinz Hartmann, Giuliano Ramadori
Scandinavian Journal of Gastroenterology
|
February 18, 2006
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication
Oliver Schildgen, Heinz Hartmann, Wolfram H Gerlich
Zeitschrift Fur Gastroenterologie
|
November 9, 2020
[Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany]
Dietrich Hüppe, Claus Niederau, Yvonne Serfert, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis
Corinna Hopf, Renate Grieshaber, Heinz Hartmann, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
March 13, 2016
[Inflammatory Bowel Disease Competence Network]
Stefan Schreiber, Heinz Hartmann, Wolfgang Kruis, et al.
BMC Gastroenterology
|
July 10, 2020
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
Ulf Helwig, Michael Mross, Stefan Schubert, et al.
The New England Journal of Medicine
|
April 28, 2006
Variant of hepatitis B virus with primary resistance to adefovir
Oliver Schildgen, Hueseyin Sirma, Anneke Funk, et al.
European Journal of Gastroenterology & Hepatology
|
July 14, 2020
Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study
Maria M Gabriel, Gerald Kircheis, Svenja Hardtke, et al.
Digestive Diseases and Sciences
|
November 19, 2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
Jörg Petersen, Renate Heyne, Stefan Mauss, et al.
The Lancet. Gastroenterology & Hepatology
|
August 19, 2017
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones, Pol F Boudes, Mark G Swain, et al.
Page
of 1